| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2014.11.005 |
| P698 | PubMed publication ID | 25448097 |
| P50 | author | Athanasios Kossyvakis | Q86107434 |
| Theodore Lytras | Q58485725 | ||
| P2093 | author name string | Andreas Mentis | |
| Nikolaos Malisiovas | |||
| Angeliki Melidou | |||
| Georgia Gioula | |||
| Maria Exindari | |||
| Vasiliki Pogka | |||
| P2860 | cites work | Molecular and phylogenetic analysis of the haemagglutinin gene of pandemic influenza H1N1 2009 viruses associated with severe and fatal infections | Q30389522 |
| The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination | Q30406109 | ||
| Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis | Q30408691 | ||
| Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children | Q30413677 | ||
| Estimation of influenza vaccine effectiveness from routine surveillance data | Q33424462 | ||
| Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates | Q33554684 | ||
| Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls | Q34215438 | ||
| After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly | Q34417196 | ||
| Estimating the influenza vaccine effectiveness against medically attended influenza in clinical settings: a hospital-based case-control study with a rapid diagnostic test in Japan | Q34550913 | ||
| Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study | Q34850986 | ||
| Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses | Q35130915 | ||
| Structural basis of immune recognition of influenza virus hemagglutinin | Q37925554 | ||
| Cochrane re-arranged: support for policies to vaccinate elderly people against influenza | Q38149671 | ||
| The test-negative design for estimating influenza vaccine effectiveness | Q38427246 | ||
| Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. | Q42227573 | ||
| Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. | Q42227574 | ||
| Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. | Q42237299 | ||
| Late season interim estimates of influenza vaccine effectiveness reliably predict end of season estimates in Victoria, Australia, 2007 to 2012. | Q42261718 | ||
| Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenza-associated hospitalizations in older adults | Q44315959 | ||
| Is it necessary to adjust for calendar time in a test negative design?: Responding to: Jackson ML, Nelson JC. The test negative design for estimating influenza vaccine effectiveness. Vaccine 2013;31(April (17)):2165-8. | Q44778385 | ||
| Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009 | Q45167855 | ||
| Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results | Q45848424 | ||
| Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. | Q50801938 | ||
| The case test-negative design for studies of the effectiveness of influenza vaccine. | Q51225150 | ||
| Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection | Q57385728 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Greece | Q41 |
| influenza vaccine | Q383260 | ||
| P1104 | number of pages | 7 | |
| P304 | page(s) | 367-373 | |
| P577 | publication date | 2014-11-18 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study | |
| P478 | volume | 33 |
| Q39700135 | Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season |
| Q59351771 | Evaluation of the field-protective effectiveness of seasonal influenza vaccine among Korean children aged < 5 years during the 2014-2015 and 2015-2016 influenza seasons: a cohort study |
| Q89600520 | Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019 |
| Q38408870 | Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013-15. |
| Q39843483 | Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study. |
| Q54270266 | Moderate influenza vaccine effectiveness against influenza A(H1N1)pdm09 virus and low effectiveness against A(H3N2) virus among older adults during 2013-2014 influenza season in Beijing, China. |
| Q38682985 | Overview of influenza vaccination policy in Beijing, China: Current status and future prospects |
| Q39813068 | Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014. |
| Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
| Q96813808 | The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus |
Search more.